analyses to women who initiated ART before 30-34 weeks and delivered after that time; 2,3 both reported excess preterm risk with preconception ART.
As noted by Stringer and colleagues, we strongly advocate that for future research on this topic, it is critical for studies to control for gestational age at ART initiation to minimise bias. We clearly state in the abstract and discussion in our paper that the benefits of ART for both maternal health and prevention of perinatal transmission outweigh the risks and "there is no question that ART should be initiated in all pregnant women and continued thereafter". We do not suggest that clinicians should withhold ART from women with HIV as a result of our findings. However, clinicians should also not withhold information on the possible risks associated with ART. Unfortunately, to date, data on the extent and severity of risks are scarce and of low quality. As the use of ART before conception increases globally, monitoring for adverse pregnancy outcomes remains a vital priority. 2,4
Data on Gestational Week ART Started

Low-middle income countries
Aniji et al (2013) On the basis of our meta-analysis, no data on helminth infection were available. It is generally known that sub-Saharan Africa has the highest prevalence of helminth infections, where most countries are lowincome. 5 Our study showed a high prevalence of T gondii infection in HIV-infected people in sub-Saharan Africa and low-income countries compared with that in middleincome countries (p=0·027) or in high-income countries (p=0·026), 1 which supports that helminth infection is a risk factor for T gondii infection in HIV-infected people in sub-Saharan Africa.
